Trump Bought Up to $5 Million of Axon Before ICE Sought $220 Million Taser Deal
Updated
Updated · CNBC · Jun 29
Trump Bought Up to $5 Million of Axon Before ICE Sought $220 Million Taser Deal
1 articles · Updated · CNBC · Jun 29
Summary
Federal disclosures show Trump bought $1 million to $5 million of Axon shares on Feb. 10, two weeks before ICE sought a five-year TASER purchase that experts said appeared tailored to Axon products.
The Feb. 24 request sought about 17,800 conductive-energy weapons, unlimited cartridges and training, with specifications—including a 45-foot range and 10 targeted probes—that reviewers said effectively matched Axon’s TASER 10.
No contract has been awarded, and a person familiar with the process said the deal appears stalled by its $220 million price tag and a DHS leadership shakeup; the White House said Trump’s assets are managed independently and denied any conflict.
Ethics experts said the timing creates an appearance problem rather than proof of wrongdoing, especially as Trump pushes mass deportations and a broader immigration-enforcement buildup that could expand demand for Axon’s weapons, cameras, software and AI tools.
Axon shares rose more than 22% in the month after Trump’s purchase and were up about 7% by June 26, implying a paper gain of roughly $350,000 if he bought near the top of the disclosed range.
Why is a $220 million Taser deal stalled despite a clear agency need and a new policy to speed up contracts?
As one company's tech ecosystem powers federal surveillance, what new privacy safeguards are needed to protect the public?
When a presidential trust invests in a company just before a major government RFI, how can conflicts of interest be truly avoided?
Trump’s Axon Investment and the $220 Million ICE Taser Deal: Conflict of Interest, Surveillance Expansion, and Calls for Reform
Overview
In early 2026, Donald Trump made a major investment in Axon Enterprise, a company known for Tasers and police technology. Just two weeks later, ICE announced a $220 million contract for Tasers, with requirements closely matching Axon's products. When Trump’s investment became public in May, it raised immediate ethical concerns about a possible conflict of interest, as critics questioned whether his financial stake could influence government contracts. This sequence of events highlights the close timing between Trump’s investment and the ICE contract notice, sparking debate over transparency and the integrity of federal procurement processes.